178 related articles for article (PubMed ID: 23493554)
1. Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK.
Wang HY; Ma CA; Zhao Y; Fan X; Zhou Q; Edmonds P; Uzel G; Oliveira JB; Orange J; Jain A
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5127-32. PubMed ID: 23493554
[TBL] [Abstract][Full Text] [Related]
2. Critical role of B cell lymphoma 10 in BAFF-regulated NF-κB activation and survival of anergic B cells.
Yu M; Chen Y; He Y; Podd A; Fu G; Wright JA; Kleiman E; Khan WN; Wen R; Wang D
J Immunol; 2012 Dec; 189(11):5185-93. PubMed ID: 23087406
[TBL] [Abstract][Full Text] [Related]
3. Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100.
Lee CE; Fulcher DA; Whittle B; Chand R; Fewings N; Field M; Andrews D; Goodnow CC; Cook MC
Blood; 2014 Nov; 124(19):2964-72. PubMed ID: 25237204
[TBL] [Abstract][Full Text] [Related]
4. TWEAK induces NF-kappaB2 p100 processing and long lasting NF-kappaB activation.
Saitoh T; Nakayama M; Nakano H; Yagita H; Yamamoto N; Yamaoka S
J Biol Chem; 2003 Sep; 278(38):36005-12. PubMed ID: 12840022
[TBL] [Abstract][Full Text] [Related]
5. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) promotes glioma cell invasion through induction of NF-κB-inducing kinase (NIK) and noncanonical NF-κB signaling.
Cherry EM; Lee DW; Jung JU; Sitcheran R
Mol Cancer; 2015 Jan; 14(1):9. PubMed ID: 25622756
[TBL] [Abstract][Full Text] [Related]
6. The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients.
Chen Y; Lind Enoksson S; Johansson C; Karlsson MA; Lundeberg L; Nilsson G; Scheynius A; Karlsson MC
PLoS One; 2011; 6(7):e22202. PubMed ID: 21765951
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of genotype-phenotype correlation in autosomal dominant anhidrotic ectodermal dysplasia with immune deficiency.
Petersheim D; Massaad MJ; Lee S; Scarselli A; Cancrini C; Moriya K; Sasahara Y; Lankester AC; Dorsey M; Di Giovanni D; Bezrodnik L; Ohnishi H; Nishikomori R; Tanita K; Kanegane H; Morio T; Gelfand EW; Jain A; Secord E; Picard C; Casanova JL; Albert MH; Torgerson TR; Geha RS
J Allergy Clin Immunol; 2018 Mar; 141(3):1060-1073.e3. PubMed ID: 28629746
[TBL] [Abstract][Full Text] [Related]
8. Context-specific BAFF-R signaling by the NF-κB and PI3K pathways.
Jellusova J; Miletic AV; Cato MH; Lin WW; Hu Y; Bishop GA; Shlomchik MJ; Rickert RC
Cell Rep; 2013 Nov; 5(4):1022-35. PubMed ID: 24239354
[TBL] [Abstract][Full Text] [Related]
9. Structural basis and targeting of the interaction between fibroblast growth factor-inducible 14 and tumor necrosis factor-like weak inducer of apoptosis.
Dhruv H; Loftus JC; Narang P; Petit JL; Fameree M; Burton J; Tchegho G; Chow D; Yin H; Al-Abed Y; Berens ME; Tran NL; Meurice N
J Biol Chem; 2013 Nov; 288(45):32261-32276. PubMed ID: 24056367
[TBL] [Abstract][Full Text] [Related]
10. Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic immunity.
Torres JM; Martinez-Barricarte R; García-Gómez S; Mazariegos MS; Itan Y; Boisson B; Rholvarez R; Jiménez-Reinoso A; del Pino L; Rodríguez-Pena R; Ferreira A; Hernández-Jiménez E; Toledano V; Cubillos-Zapata C; Díaz-Almirón M; López-Collazo E; Unzueta-Roch JL; Sánchez-Ramón S; Regueiro JR; López-Granados E; Casanova JL; Pérez de Diego R
J Clin Invest; 2014 Dec; 124(12):5239-48. PubMed ID: 25365219
[TBL] [Abstract][Full Text] [Related]
11. TNF-like weak inducer of apoptosis (TWEAK) activates proinflammatory signaling pathways and gene expression through the activation of TGF-beta-activated kinase 1.
Kumar M; Makonchuk DY; Li H; Mittal A; Kumar A
J Immunol; 2009 Feb; 182(4):2439-48. PubMed ID: 19201899
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.
Chen T; Guo ZP; Li MM; Li JY; Jiao XY; Zhang YH; Liu HJ
Clin Exp Immunol; 2011 Oct; 166(1):64-71. PubMed ID: 21762126
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-like weak inducer of apoptosis inhibits skeletal myogenesis through sustained activation of nuclear factor-kappaB and degradation of MyoD protein.
Dogra C; Changotra H; Mohan S; Kumar A
J Biol Chem; 2006 Apr; 281(15):10327-36. PubMed ID: 16461349
[TBL] [Abstract][Full Text] [Related]
14. Pathological activation of canonical nuclear-factor κB by synergy of tumor necrosis factor α and TNF-like weak inducer of apoptosis in mouse acute colitis.
Dohi T; Kawashima R; Kawamura YI; Otsubo T; Hagiwara T; Amatucci A; Michaelson J; Burkly LC
Cytokine; 2014 Sep; 69(1):14-21. PubMed ID: 25022957
[TBL] [Abstract][Full Text] [Related]
15. Bruton's tyrosine kinase mediates NF-kappa B activation and B cell survival by B cell-activating factor receptor of the TNF-R family.
Shinners NP; Carlesso G; Castro I; Hoek KL; Corn RA; Woodland RT; Scott ML; Wang D; Khan WN
J Immunol; 2007 Sep; 179(6):3872-80. PubMed ID: 17785824
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
17. Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease.
Lougaris V; Tabellini G; Vitali M; Baronio M; Patrizi O; Tampella G; Biasini A; Moratto D; Parolini S; Plebani A
J Allergy Clin Immunol; 2015 Jun; 135(6):1641-3. PubMed ID: 25605273
[No Abstract] [Full Text] [Related]
18. Soluble and transmembrane TNF-like weak inducer of apoptosis differentially activate the classical and noncanonical NF-kappa B pathway.
Roos C; Wicovsky A; Müller N; Salzmann S; Rosenthal T; Kalthoff H; Trauzold A; Seher A; Henkler F; Kneitz C; Wajant H
J Immunol; 2010 Aug; 185(3):1593-605. PubMed ID: 20610643
[TBL] [Abstract][Full Text] [Related]
19. Combined immune deficiency in a patient with a novel NFKB2 mutation.
Lindsley AW; Qian Y; Valencia CA; Shah K; Zhang K; Assa'ad A
J Clin Immunol; 2014 Nov; 34(8):910-5. PubMed ID: 25205549
[TBL] [Abstract][Full Text] [Related]
20. Non-parametric Heat Map Representation of Flow Cytometry Data: Identifying Cellular Changes Associated With Genetic Immunodeficiency Disorders.
Ellyard JI; Tunningley R; Lorenzo AM; Jiang SH; Cook A; Chand R; Talaulikar D; Hatch AM; Wilson A; Vinuesa CG; Cook MC; Fulcher DA
Front Immunol; 2019; 10():2134. PubMed ID: 31572362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
